Question 1

What are the differences between aprepitant and ondansetron in terms of effectiveness and side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) clinical trial (NCT00092183). Contact the study team or your healthcare provider for specific answers.

Question 2

How might participating in this trial affect my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) clinical trial (NCT00092183). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of aprepitant?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) clinical trial (NCT00092183). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) clinical trial (NCT00092183). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I do if I experience nausea or vomiting during my chemotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) clinical trial (NCT00092183). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any other treatment options available for managing nausea and vomiting?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) clinical trial (NCT00092183). Contact the study team or your healthcare provider for specific answers.

What this study is about